The co-founders of NEUROSTECH, Gabriel Álvarez Menéndez (CEO) and Catuxa Prado (CSO), were recently featured in the latest episode of the Venus Founders Podcast, hosted by Mariel Díaz. In this episode, they discuss the company’s pioneering work in the field of neuro-medical therapies and share insights into the innovation behind their implantable devices aimed at treating neurodegenerative diseases.
The episode delves into the technological advancements NEUROSTECH is making in the MedTech sector, positioning the company as one of the most promising in its field. Gabriel and Catuxa also reflect on the challenges they have faced as entrepreneurs and the resilience required to bring their cutting-edge technology to market.
Their journey underscores the importance of experience and adaptability, as key factors in advancing innovation for the treatment of neurodegenerative diseases.
